DonaldSt. PaulGravenorMD

PubMed

• 69 citations
  Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
  Ulrich Keilholz, Janice M. Mehnert, Sebastian Bauer, Hugues Bourgeois, Manish R. Patel, Donald Gravenor, John Nemunaitis, Matthew H. Taylor, Lucjan Wyrwicz, Keun Wook ...> ;Journal for Immunotherapy of Cancer. 2019 Jan 16
• 17 citations
  TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
  Denise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky, David Drosick, Fred J. Kudrik, Linda D. Bosserman, Mark Keaton, Sharon A. Goble,...> ;Breast Cancer Research and Treatment. 2017 May 15
• Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy.
  Berenson JR, Hilger JD, Yellin O, Dichmann R, Patel-Donnelly D, Boccia RV, Bessudo A, Stampleman L, Gravenor D, Eshaghian S, Nassir Y, Swift RA, Vescio RA> ;Leukemia. 2014-07-01
• 46 citations
  Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
  James R. Berenson, Ori Yellin, Alberto Bessudo, Ralph V. Boccia, Stephen J. Noga, Donald S. Gravenor, Dipti Patel-Donnelly, Robert S. Siegel, Tarun Kewalramani, Edward...> ;British Journal of Haematology. 2013 Feb 1
• 2 citations
  A Retrospective Study to Evaluate the Work-up and Follow-up of Patients With Monoclonal Gammopathy of Undetermined Significance
  James R. Berenson, Ori Yellin, Albert T. Quiery, James O. Brady, Ravi K. Patel, Siu Fun Wong, Donald Steven Colbourn, Donald S. Gravenor, Natasha M. Tiffany, H. K. Sha...> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Aug 1
• Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial.
  Berenson JR, Yellin O, Bessudo A, Boccia R, Noga S, Gravenor D, Patel-Donnelly D, Siegel RS, Kewalramani T, Gorak EJ, Swift R, Bensen-Kennedy D> ;J. Clin. Oncol.. 2011-05-20
• 19 citations
  Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid
  James R. Berenson, Ori Yellin, John Crowley, Adel Z. Makary, Donald S. Gravenor, Hank H. Yang, Gargi Upadhyaya, Ian W. Flinn, Harry Staszewski, Natasha M. Tiffany, Sha...> ;American Journal of Hematology. 2011 Jan 1
• Factors that determine survival among patients with multiple myeloma (MM) treated with zoledronic acid (ZOL).
  Yellin O, Crowley J, Swift RA, Makary A, Gravenor DS, Yang HH, Upadhyaya GH, Flinn IW, Staszewski H, Tiffany NM, Berenson JR> ;J. Clin. Oncol.. 2009-05-20
• 123 citations
  Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Adva...
  Christian Manegold, Donald Gravenor, Donald Woytowitz, J. Mezger, Vera Hirsh, Gary Albert, Mohammed J Al-Adhami, David Robert John Readett, Arthur M. Krieg, Cynthia G....> ;Journal of Clinical Oncology. 2008 Aug 20
• 1 citations
  Clinical and radiologic resolution of IgG 4 normal, nonoperatively diagnosed lymphoplasmacytic sclerosing pancreatitis (LPSP) after initiation of steroid therapy.
  Stephen W. Behrman, Shamim M. Moinuddin, Donald S. Gravenor> ;Journal of Gastrointestinal Surgery. 2007 Feb 10
• CPG 7909, a TLR9 agonist, added to first line taxane/platinum for advanced non-small cell lung cancer, a randomized, controlled phase II study.
  Leichman G, Gravenor D, Woytowitz D, Mezger J, Albert G, Schmalbach T, Al-Adhami M, Manegold C> ;J. Clin. Oncol.. 2005-06-01
• A TLR9 CpG immunomodulator in combination with chemotherapy as treatment for advanced non-small cell lung cancer (NSCLS), a randomized, controlled phase II study.
  Leichman G, Gravenor D, Albert G, Schmalbach T> ;J. Clin. Oncol.. 2004-07-15
• Tricyclic antidepressant agranulocytosis.
  Gravenor, D. S., Leclerc, J. R., Blake, G.> ;Can J Psychiatry. 1986 Oct 01
• Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
  Panasci, L., Gravenor, D., Black, M., Frenkiel, S., Margolese, R.> ;Cancer Treat Rep. 1985 Sep
• 5 alpha-androstane-3 alpha, 17 beta-diol: inhibitor of sexual maturation in the female rat.
  Kraulis, I., Naish, S. J., Gravenor, D., Ruf, K. B.> ;Biol Reprod. 1981 Mar
• Join now to see all